Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes
NCT ID: NCT06927700
Last Updated: 2025-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1257 participants
INTERVENTIONAL
2025-04-24
2025-05-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
NCT07102082
Novel Determinants and Measures of Smokeless Tobacco Use: Study 1
NCT01067586
Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior
NCT06192316
Responses of Adults Smoking Nondaily and Daily in the Experimental Tobacco Marketplace
NCT06988371
The Impact of Cigarillo Warnings on Purchasing
NCT05434013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 (General Snus-Control Ads)
Participants in this group will view 4 ads for the brand General Snus that do not include a modified risk claim.
Modified Risk Claim Type - None
Participants will view smokeless tobacco ads with no modified risk claim (control)
Product Brand - General Snus
Participants will views ads for the smokeless tobacco brand General Snus
Group 2 (General Snus-Multiple Disease Ads)
Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of multiple diseases.
Product Brand - General Snus
Participants will views ads for the smokeless tobacco brand General Snus
Modified Risk Claim Type - Multiple Diseases
Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases
Group 3 (General Snus- Lung Ads)
Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only.
Product Brand - General Snus
Participants will views ads for the smokeless tobacco brand General Snus
Modified Risk Claim Type - Lung Cancer
Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only
Group 4 (Copenhagen-Control Ads)
Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim.
Modified Risk Claim Type - None
Participants will view smokeless tobacco ads with no modified risk claim (control)
Product Brand - Copenhagen
Participants will views ads for the smokeless tobacco brand Copenhagen
Group 5 (Copenhagen-Multiple Disease Ads)
Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases.
Product Brand - Copenhagen
Participants will views ads for the smokeless tobacco brand Copenhagen
Modified Risk Claim Type - Multiple Diseases
Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases
Group 6 (Copenhagen- Lung Ads)
Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only.
Product Brand - Copenhagen
Participants will views ads for the smokeless tobacco brand Copenhagen
Modified Risk Claim Type - Lung Cancer
Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modified Risk Claim Type - None
Participants will view smokeless tobacco ads with no modified risk claim (control)
Product Brand - General Snus
Participants will views ads for the smokeless tobacco brand General Snus
Product Brand - Copenhagen
Participants will views ads for the smokeless tobacco brand Copenhagen
Modified Risk Claim Type - Multiple Diseases
Participants will view smokeless tobacco ads with a claim about lower risks for multiple diseases
Modified Risk Claim Type - Lung Cancer
Participants will either view smokeless tobacco ads with a modified risk claim about lower risks for lung cancer only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olivia A. Wackowski, PhD, MPH
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivia A Wackowski, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Rutgers University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rutgers Institute for Nicotine & Tobacco Studies
New Brunswick, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
Information about FDA's authorization of modified risk order for Copenhagen snuff
Information about FDA's authorization of modified risk order for General Snus products
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro2024000097
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.